Ketorolac, melatonin and latanoprost tri-loaded PLGA microspheres for neuroprotection in glaucoma.

Drug Deliv · 2025 · PMC11995771 · PMID 40211987

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Interestingly, the Glaucoma + IV treatment KMLVE cohort showed a trend of functional improvement, with shorter latencies and greater PhNR amplitude (Glaucoma + IV treatment KMLVE > Control > Glaucoma) (PhNRwave: 22.02 ± 18.07 vs 11.75 ± 11.94 vs 5.66 ± 4.57 mV; p = 0.126), at week 24 ( Table 6 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.